Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare ...(1b trial evaluating thesafety and tolera...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
Date:8/30/2007
1b trial evaluating the safety and tolerability of MT201 in combination with docetaxel is currently ongoing in patients with metastatic breast cancer. Our third clinical stage product candidate is D93, also known as TRC093, a first-in- class humanized monoclonal antibody that inhibits angiogenesis and tumor cell growth by binding cleaved collagen. This product candidate is in phase 1 clinical trials and is being developed by TRACON Pharmaceuticals for the treatment of patients with cancer and age-related macular degeneration pursuant to license agreement under which Micromet has granted TRACON the worldwide rights to develop and commercialize D93/TRC093. In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, Micromet's human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as autoimmune diseases.
'/>"/>
| SOURCE Micromet, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
Breaking Biology Technology:Eidogen-Sertanty Licenses TIP to the FDA 2Boost for Prostate Cancer Screening - Report Shows Mortality Reduction as High as 31% 2New technology could boost disease detection tests' speed and sensitivity 2
Other Biology Technology:Request to re-examine WARF stem cell patents escalates war of words 2Request to re-examine WARF stem cell patents escalates war of words 3Technology in the Northwoods 2Technology in the Northwoods 3Prodesse joins forces with Invitrogen 2
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 277 percent of European pigs are castrated without anesthetic 2St Josephs Healthcare System Implements 24250 Million Five Year Facilities Project at Paterson and Wayne Campuses 54658 1St Josephs Healthcare System Implements 24250 Million Five Year Facilities Project at Paterson and Wayne Campuses 54658 2St Josephs Healthcare System Implements 24250 Million Five Year Facilities Project at Paterson and Wayne Campuses 54658 3St Josephs Healthcare System Implements 24250 Million Five Year Facilities Project at Paterson and Wayne Campuses 54658 4St Josephs Healthcare System Implements 24250 Million Five Year Facilities Project at Paterson and Wayne Campuses 54658 5Hurricane Season Heats Up 54655 1Hurricane Season Heats Up 54655 2Hurricane Season Heats Up 54655 3Gene vital to brains stem cells implicated in deadly brain cancer 54651 1Gene vital to brains stem cells implicated in deadly brain cancer 54651 2Gene vital to brains stem cells implicated in deadly brain cancer 54651 3
Other Biology News:Shellfish face an uncertain future in a high CO2 world 2Shellfish face an uncertain future in a high CO2 world 3Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 2Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 3Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 4Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 5Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 6Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 7Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 8Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 9Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 10Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 11
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |